Molluscum Contagiosum (Child)
Summary
Molluscum contagiosum is a Common, Benign, Self-Limiting Viral Skin Infection caused by the Molluscum Contagiosum Virus (MCV), a member of the Poxviridae family. It is characterised by Discrete, Dome-Shaped, Umbilicated Papules with a central dimple (Umbilication) containing a white, waxy core. The condition is extremely common in Children aged 1-10 years, spread by Direct Skin-to-Skin Contact, Autoinoculation, and Fomites. Lesions typically appear on the Face, Trunk, Axillae, and Limbs in children. In Immunocompetent patients, molluscum is Self-Limiting, resolving spontaneously within 6-18 months (Sometimes up to 2-4 years) without scarring. Treatment is often Unnecessary but may be considered for cosmetic reasons, To prevent spread, Or if lesions are symptomatic. Options include Physical Destruction (Cryotherapy, Curettage), Topical Agents (Potassium Hydroxide, Imiquimod), and Watchful Waiting (Preferred). In Immunocompromised patients (HIV/AIDS), molluscum can be extensive, Giant, And recalcitrant, serving as a marker of disease. [1,2,3]
Key Facts
| Fact | Value |
|---|---|
| Definition | Viral skin infection with umbilicated papules |
| Causative Agent | Molluscum Contagiosum Virus (MCV), Poxviridae |
| Peak Age | 1-10 years |
| Transmission | Direct contact, Autoinoculation, Fomites |
| Incubation | 2-6 weeks (Up to 6 months) |
| Duration (Untreated) | 6-18 months (Range 6 months - 4 years) |
| Diagnosis | Clinical (Characteristic appearance) |
| Treatment | Watchful waiting (First-line) |
Clinical Pearls
"Umbilicated Papules with Central Dimple": Pathognomonic appearance.
"Leave Them Alone": Self-limiting in immunocompetent. Watch and wait is first-line.
"BOTE Sign": Beginning Of The End – Inflammatory reaction around lesions signals immune clearance.
"Extensive or Giant Molluscum = Consider Immunodeficiency": Screen for HIV if appropriate.
"Molluscum Dermatitis": Eczematous reaction around lesions – Treat with emollients/Mild TCS.
Why This Matters Clinically
Molluscum contagiosum is one of the most common viral skin infections in children and a frequent presentation in primary care and paediatric dermatology. Although benign and self-limiting, it causes significant parental anxiety and school exclusion debates. Understanding the natural history is essential to avoid unnecessary, Potentially scarring interventions. Recognition of atypical or extensive molluscum is important as it may indicate underlying immunodeficiency. This condition is commonly examined due to its characteristic clinical appearance and management decision-making.
Global Burden
| Metric | Data | Notes |
|---|---|---|
| Worldwide Prevalence | 2-10% of children | Higher in tropical regions |
| Peak Prevalence Age | 1-10 years | Immune-naive population |
| Annual Incidence | 0.1-0.5% in developed countries | Higher in developing regions |
| Consultation Rate | 5-10% of paediatric dermatology referrals | Common reason for consultation |
| Economic Burden | Significant | Parental anxiety, Unnecessary treatments, School exclusion debates |
Incidence & Prevalence by Age
| Age Group | Prevalence | Notes |
|---|---|---|
| Infants (less than 1 year) | Less than 1% | Rare, Maternal antibodies may provide protection |
| Toddlers (1-3 years) | 3-5% | Increasing with daycare exposure |
| Preschool (3-5 years) | 5-8% | Peak onset age |
| School Age (5-10 years) | 5-10% | Peak prevalence |
| Adolescents (10-18 years) | 2-4% | Decreasing, Prior immunity |
| Adults | 1-2% | Often sexually transmitted in this age group |
Geographic Distribution
| Region | Prevalence | Factors |
|---|---|---|
| Tropical/Subtropical | Higher (Up to 15%) | Heat, Humidity, Skin exposure, Overcrowding |
| Temperate Developed | Lower (2-8%) | Better hygiene, Less crowding |
| Sub-Saharan Africa | Very High (Up to 20%) | HIV epidemic, Overcrowding |
| Asia-Pacific | Moderate-High | Variable by country |
| Middle East | Moderate | Traditional dress may reduce skin contact |
Demographics
| Factor | Details | Clinical Significance |
|---|---|---|
| Age | Peak 1-10 years, Median onset 5 years | Immune naïve to MCV |
| Sex | Equal male:female ratio | No sex predilection |
| Ethnicity | All ethnicities affected equally | No racial predilection |
| Socioeconomic | May be higher in lower SES (Overcrowding) | Increased contact transmission |
| Setting | Daycare, Schools, Swimming pools, Sports | Close contact environments |
Transmission Patterns
| Mode | Contribution | Details |
|---|---|---|
| Direct Skin-to-Skin Contact | Primary (60-70%) | Play, Wrestling, Contact sports, Bathing together |
| Autoinoculation | Major (Secondary spread) | Scratching spreads to new sites on same child |
| Fomites | Moderate (20-30%) | Towels, Clothing, Bath toys, Gym equipment |
| Swimming Pools | Debated (Low-Moderate) | May be pool surroundings rather than water itself |
| Sexual Transmission | Adults | Genital MC in adults typically sexually transmitted |
Transmission Settings
| Setting | Risk Level | Prevention |
|---|---|---|
| Household/Siblings | High | Avoid sharing towels, Separate bathing |
| Daycare/Nursery | Moderate-High | General hygiene, Cover lesions |
| Swimming Pools | Low-Moderate | Cover lesions (Optional), Not mandatory exclusion |
| Contact Sports | Moderate | Cover lesions during activity |
| Schools | Low | No exclusion required |
Risk Factors for Acquisition
| Factor | Relative Risk | Mechanism |
|---|---|---|
| Young Age (1-10 years) | High (Baseline) | Immune naïve to MCV |
| Atopic Dermatitis/Eczema | RR 3-4 | Impaired skin barrier, Xerosis, Increased scratching |
| Immunodeficiency (HIV) | Very High | Impaired T-cell immunity |
| Close Household Contact | RR 2-3 | Direct transmission opportunity |
| Sibling with MC | RR 2-4 | Prolonged close contact |
| Swimming Pool Use | RR 1.5-2 (Debated) | Fomite/Contact spread in changing areas |
| Shared Bathing | Moderate | Direct contact, Fomites |
| Daycare Attendance | Moderate | Multiple contacts |
| Overcrowding | Moderate | Increased contact opportunity |
Risk Factors for Extensive or Prolonged Disease
| Factor | Notes | Management Implication |
|---|---|---|
| HIV/AIDS | Giant molluscum, 100s of lesions, Recalcitrant | Test for HIV if extensive. Optimise ART. |
| Primary Immunodeficiency | T-cell defects (SCID, DiGeorge) | Immunology referral. Aggressive treatment. |
| Immunosuppressive Therapy | Transplant, Chemotherapy, Biologics | Reduce immunosuppression if possible. Treat lesions. |
| Atopic Dermatitis | More lesions, Longer duration | Treat eczema. Emollients. |
| Extensive Scratching | Autoinoculation spreads disease | Discourage scratching. Trim nails. |
Seasonal Variation
| Season | Incidence | Possible Reasons |
|---|---|---|
| Summer | Higher | More skin exposure, Swimming, Increased contact |
| Winter | Lower | More clothing, Less direct contact |
| School Year | Moderate | Increased contact in settings |
| Holidays | May increase | Swimming, Camps, Family contact |
Virology
| Feature | Details |
|---|---|
| Virus | Molluscum Contagiosum Virus (MCV) |
| Family | Poxviridae |
| Subtypes | MCV-1 (Most common, Children), MCV-2 (Adults, Sexually transmitted) |
| Genome | Double-stranded DNA |
| Host | Humans only |
| Target | Keratinocytes of epidermis |
Mechanism
Step 1: Viral Entry and Infection
- Transmission: Direct skin-to-skin contact, Autoinoculation (Scratching), Fomites
- Entry: Virus enters through minor breaks in epidermis
- Target Cells: Basal keratinocytes
- No Viraemia: Infection remains localised to epidermis
Step 2: Viral Replication
- Incubation: 2-6 weeks (Can be up to 6 months)
- Replication: Virus replicates in keratinocyte cytoplasm
- Henderson-Patterson Bodies: Inclusion bodies (Molluscum bodies) – Aggregates of viral particles in cytoplasm
- No incorporation into host DNA
Step 3: Lesion Development
- Hyperplasia: Infected keratinocytes proliferate
- Lobulated Growth: Epidermis extends into dermis
- Central Core: Keratinocytes filled with viral particles (White cheesy material)
- Umbilication: Central dimple forms as superficial cells shed
Step 4: Immune Evasion
- Localised Infection: No systemic spread
- Immune Evasion Proteins: MCV produces proteins that inhibit inflammatory response
- Delayed Recognition: Virus "hides" from immune system
- Explains prolonged course: Months to years before clearance
Step 5: Immune Clearance (BOTE Sign)
- Cell-Mediated Immunity: Eventually recognises infection
- Inflammatory Response: Lesions become red, Swollen, Tender
- "Beginning Of The End" (BOTE): Inflammation signals immune clearance
- Resolution: Lesions resolve, Usually without scarring
- Post-Inflammatory Changes: Temporary hypopigmentation/Hyperpigmentation possible
Histology
| Finding | Description |
|---|---|
| Molluscum Bodies (Henderson-Patterson Bodies) | Large eosinophilic intracytoplasmic inclusion bodies. Pathognomonic. |
| Epidermal Hyperplasia | Lobulated proliferation extending into dermis |
| Central Crater | Contains keratinised debris and virus |
| Minimal Inflammation | Until resolution phase |
Overview of Presentation
| Aspect | Details |
|---|---|
| Typical Patient | Child aged 2-8 years with clusters of small papules |
| Onset | Gradual, Often unnoticed initially |
| Course | Waxing and waning over months |
| Resolution | Spontaneous, Usually within 6-18 months |
| Parental Concern | Common, Often disproportionate to severity |
Lesion Morphology - Detailed
| Feature | Description | Distinguishing Points |
|---|---|---|
| Shape | Dome-shaped, Hemispherical papules | Rounded, Not flat-topped |
| Size | 1-5mm typically | Up to 10-15mm = Giant molluscum (Red flag) |
| Surface | Smooth, Shiny, Waxy | Unlike warts which are rough |
| Colour | Flesh-coloured, Pink, White, Pearly | May have slight translucency |
| Umbilication | Central dimple (Pathognomonic) | May need magnification or dermoscopy to see |
| Core | White, Cheesy, Waxy material expressible | Molluscum body - contains viral particles |
| Number | Few to hundreds. Average 10-20. | Extensive = Consider immunodeficiency |
| Grouping | Often clustered | Autoinoculation creates satellite lesions |
| Base | Non-erythematous (Unless BOTE or infected) | Erythema suggests inflammation |
Severity Staging
| Stage | Number of Lesions | Description | Management Approach |
|---|---|---|---|
| Minimal | 1-5 | Few isolated lesions | Watchful waiting |
| Mild | 6-20 | Scattered lesions, Limited areas | Watchful waiting OR treat if requested |
| Moderate | 21-50 | Multiple areas involved | Consider treatment if distressing |
| Extensive | 51-100 | Widespread involvement | Consider immunodeficiency. May warrant treatment. |
| Severe | Greater than 100 | Very extensive, May be confluent | Investigate immunodeficiency. Specialist referral. |
Distribution Patterns
Common Distribution (Children):
| Site | Frequency | Notes |
|---|---|---|
| Face | Very Common (30-40%) | Especially periocular, Cheeks |
| Eyelids | Common | May cause chronic conjunctivitis |
| Trunk | Very Common (40-50%) | Chest, Abdomen, Back |
| Axillae | Common | Intertriginous area |
| Antecubital Fossae | Common | Flexural predilection |
| Popliteal Fossae | Common | Behind knees |
| Upper Arms | Common | Accessible to scratching |
| Thighs | Moderate | Inner thighs especially |
| Genital Area (Children) | 5-10% | Non-sexual transmission via bathing, Contact |
| Buttocks | Moderate | Bathing/Sitting transmission |
Distribution in Adults:
| Site | Notes |
|---|---|
| Genital/Perigenital | Predominant in sexually transmitted cases |
| Lower Abdomen | |
| Inner Thighs | |
| Face (Adults + HIV) | May be extensive with HIV |
Symptom Analysis
| Symptom | Frequency | Severity | Notes |
|---|---|---|---|
| Asymptomatic | 70-80% | None | Most children have no symptoms from lesions |
| Mild Pruritus | 15-20% | Mild | Especially with associated eczema |
| Cosmetic Concern | Very Common | Variable | Parental anxiety common |
| Pain | Rare | Minimal | Only with secondary infection |
| Tenderness | 10% | Mild | Especially during BOTE phase |
| Secondary Infection Symptoms | 5-10% | Mild-Moderate | Erythema, Warmth, Pustules, Crusting |
Timeline and Evolution
| Phase | Duration | Clinical Features |
|---|---|---|
| Incubation | 2-6 weeks (Up to 6 months) | No visible lesions |
| Early/New Lesions | Weeks | Small, May lack obvious umbilication |
| Established Lesions | Months | Classic dome-shaped, Umbilicated appearance |
| Autoinoculation Phase | Variable | Number may increase if scratched |
| BOTE Phase | 1-4 weeks | Lesions become inflamed, Red, Tender |
| Resolution | 1-4 weeks per lesion | Lesions shrink and disappear |
| Post-Inflammatory | Weeks-Months | Temporary pigment changes possible |
Associated Features - Detailed
| Feature | Incidence | Description | Management |
|---|---|---|---|
| Molluscum Dermatitis | 10-30% | Eczematous/Erythematous reaction around lesions. Immune response, Not infection. Pruritic. | Emollients, Mild topical corticosteroids (HC 1%) |
| Eczema Molluscatum | Variable | Superimposed eczema herpeticum-like appearance | May mimic bacterial infection. Ensure not truly infected. |
| Koebnerisation | Common | New lesions appearing along sites of trauma (scratches) | Discourage scratching |
| BOTE Sign | Precedes resolution | Inflamed, Red, Swollen, Tender lesions | Reassure. This signals resolution. No treatment needed. |
| Satellite Lesions | Common | Clustering around original lesions | Result of autoinoculation |
Age-Related Variations
| Age Group | Typical Features |
|---|---|
| Toddlers (1-3 years) | Few lesions, May increase, Often facial |
| Preschool (3-5 years) | More lesions, Trunk/limbs, May spread in daycare |
| School Age (5-10 years) | Most common presentation, Variable severity |
| Adolescents | Less common, May have genital lesions |
| Adults | Genital predominant (STI), Or extensive if immunocompromised |
Atypical Presentations - Expanded
| Presentation | Incidence | Context | Action |
|---|---|---|---|
| Giant Molluscum (greater than 1cm) | Rare | Immunocompromised, HIV | Test for HIV if risk. Optimise immunity. |
| Extensive (greater than 50-100 lesions) | 5-10% | Immunocompromised, Atopic dermatitis | Screen for immunodeficiency |
| Facial/Eyelid Predominant | 20-30% | Normal variant in children | May need treatment if causing conjunctivitis |
| Inflamed Lesions | Common | BOTE (Resolving) OR Secondary infection | Differentiate: BOTE = Red, Tender. Infection = Pustules, Spread. |
| Genital in Prepubescent | To consider | Usually non-sexual (bathing, contact) | Consider but do not assume abuse. Context important. |
| Unilateral Distribution | Occasional | May follow lymphatic drainage | Check not zosteriform distribution (HSV) |
| Pedunculated | Rare | Stalk-like attachment | May be confused with skin tag |
| Eczematous | With underlying AD | Extensive, Pruritic, Surrounded by dermatitis | Treat eczema aggressively |
Red Flags - Detailed
[!CAUTION] Red Flags – Investigate for Immunodeficiency:
- Giant molluscum (greater than 1cm diameter)
- Extensive disease (greater than 50-100 lesions)
- Recalcitrant, Not resolving after 2-4 years
- Atypical sites or distribution
- Associated with other opportunistic infections
- Adult with extensive facial lesions
- Failure to develop BOTE reaction
Action: Consider HIV testing, Immunology referral, Full immunodeficiency workup
Differential Features
| Condition | Distinguishing from Molluscum |
|---|---|
| Warts (Verruca) | Rough, Keratotic surface. No central umbilication. Often filiform. |
| Milia | White, Firm. Smaller. No umbilication. Usually face only. |
| Folliculitis | Pustular, Hair-centred. May be tender. |
| Keratosis Pilaris | Rough, Follicular. Arms/Thighs. No umbilication. |
| Lichen Planus | Polygonal, Flat-topped, Purple. Wickham striae. |
| Insect Bites | Red, Pruritic papules. Central punctum. Clustering different. |
| Cryptococcosis (HIV) | Umbilicated but immunocompromised. Systemic symptoms. |
| Histoplasmosis (HIV) | Similar disseminated papules in HIV. Systemic illness. |
Overview
| Purpose | Approach |
|---|---|
| Confirm Diagnosis | Identify characteristic umbilicated papules |
| Assess Severity | Count and map lesions |
| Identify Complications | Secondary infection, Molluscum dermatitis |
| Exclude Red Flags | Giant/Extensive (Immunodeficiency), Atypical features |
| Plan Management | Watchful waiting vs Treatment indicated |
Structured Approach
Step 1: General Inspection
| Element | What to Look For |
|---|---|
| General Health | Child appears well (Systemically well) |
| Skin Overview | Distribution of lesions, Number |
| Associated Skin Conditions | Atopic dermatitis (Predisposes), Other infections |
| Scarring | Previous lesions or treatments |
| Signs of Scratching | Linear marks, Excoriations |
Step 2: Lesion Characterisation
| Feature | Expected Finding in Molluscum | Red Flag |
|---|---|---|
| Shape | Dome-shaped, Hemispherical | Irregular = Consider other diagnosis |
| Size | 1-5mm (Up to 10mm) | Greater than 15mm = Giant molluscum |
| Colour | Flesh, Pink, Pearly, White | Very red = Infection or BOTE |
| Surface | Smooth, Shiny, Waxy | Rough = Consider wart |
| Umbilication | Central dimple present | Absent rare, Use magnification |
| Number | Variable (1 to hundreds) | Greater than 50-100 = Consider immunodeficiency |
| Grouping | May cluster, Satellite lesions | Widespread = Screen for immune issues |
Step 3: Distribution Mapping
| Site | Tick if Involved | Number | Notes |
|---|---|---|---|
| Face | ☐ | ||
| Eyelids | ☐ | Ophthalmology referral if symptomatic | |
| Trunk | ☐ | ||
| Axillae | ☐ | ||
| Arms | ☐ | ||
| Legs | ☐ | ||
| Genital/Perineal | ☐ | Note if child or adult | |
| Other | ☐ |
Step 4: Assessment of Complications
| Complication | Signs to Look For |
|---|---|
| BOTE Sign | Red, Swollen, Tender lesions (Good sign = Resolution) |
| Secondary Infection | Spreading erythema, Warmth, Pustules, Crusting, Pus |
| Molluscum Dermatitis | Eczematous changes around lesions (Not infection) |
| Scarring | From previous treatment or infection |
Step 5: Examination of Surrounding Skin
| Feature | Finding | Significance |
|---|---|---|
| Eczema | Dry, Scaly, Erythematous patches | Associated condition. Predisposes. Treat. |
| Excoriations | Scratch marks | Autoinoculation risk. Counsel on scratching. |
| Pigment Changes | Hypo/Hyperpigmentation | Post-inflammatory. Usually temporary. |
Dermoscopy Findings
| Feature | Description | Significance |
|---|---|---|
| Central White-Yellow Structure | Amorphous, Homogeneous | Core of molluscum (Virus-laden cells) |
| Crown/Clover Leaf Vessels | Peripheral radiating vessels | Characteristic pattern |
| Polylobular Pattern | Multiple lobules | Seen in established lesions |
| Orifice | Central opening | May express core |
Lesion Expression/Testing
| Test | Technique | Expected Finding |
|---|---|---|
| Gentle Squeeze | Apply lateral pressure to lesion | White, Cheesy, Waxy core may be expressed |
| Core Examination | Examine expressed material | Contains molluscum bodies |
| Note | This is diagnostic but not necessary | Clinical diagnosis usually sufficient |
Other Examination Components
| Element | What to Examine | Findings in Uncomplicated MC |
|---|---|---|
| Lymph Nodes | Regional lymphadenopathy | Absent (Unless secondary infection) |
| Eyes (If Eyelid Lesions) | Conjunctival injection, Discharge | May have chronic follicular conjunctivitis |
| General Examination | Signs of immunodeficiency | Normal in typical cases |
Documentation
Record the Following:
| Item | Example Documentation |
|---|---|
| Number | "Approximately 15-20 lesions" |
| Size Range | "2-5mm in diameter" |
| Distribution | "Predominantly trunk and upper limbs" |
| Morphology | "Dome-shaped, Umbilicated papules" |
| Complications | "No signs of BOTE or secondary infection" |
| Associated Conditions | "Background atopic dermatitis noted on flexures" |
| Diagnosis | "Clinical diagnosis: Molluscum contagiosum" |
Special Tests Summary
| Test | Technique | Positive Finding | Significance |
|---|---|---|---|
| Dermoscopy | Examine with dermatoscope | White-yellow central structure, Crown vessels | Confirms diagnosis |
| Expression of Core | Gentle squeeze or curettage | White cheesy material | Characteristic |
| Wood's Lamp | UV examination | Not specific | Exclude tinea |
| Biopsy | Rarely needed | Henderson-Patterson bodies | If diagnosis uncertain |
Diagnosis is Clinical
Investigations are NOT usually required. Diagnosis is based on characteristic clinical appearance. The presence of dome-shaped, umbilicated papules is sufficient for diagnosis in most cases.
Diagnostic Certainty:
| Presentation | Investigations Needed |
|---|---|
| Typical appearance (Umbilicated papules) | None required |
| Atypical features | Consider dermoscopy first |
| Still uncertain | Skin biopsy for histology |
| Giant/Extensive | HIV test if risk factors |
When to Investigate
| Investigation | Indication | Expected Finding |
|---|---|---|
| Dermoscopy | Confirm diagnosis, Atypical lesions | Central white structure, Crown vessels |
| Skin Biopsy | Atypical appearance, Diagnostic uncertainty | Henderson-Patterson bodies |
| HIV Test | Extensive/Giant molluscum, Adult with genital lesions | Rule out immunodeficiency |
| STI Screen | Adult genital molluscum | Comprehensive screen |
| Full Blood Count | If immunodeficiency suspected | Lymphopenia, Other abnormalities |
| Immunoglobulins | If primary immunodeficiency suspected | Low levels |
Histopathology (If Performed)
| Finding | Description | Significance |
|---|---|---|
| Henderson-Patterson Bodies | Large eosinophilic intracytoplasmic inclusions | Pathognomonic |
| Molluscum Bodies | Same as above – Viral inclusion bodies | Diagnostic |
| Lobulated Epidermal Hyperplasia | Epidermis extends into dermis in lobules | Characteristic architecture |
| Central Crater | Opens to surface | Contains keratinised debris |
| Minimal Inflammation | Unless BOTE phase | Immune evasion |
Differential Diagnosis - Detailed
| Condition | Key Features | How to Distinguish |
|---|---|---|
| Warts (Verruca Vulgaris) | Rough, Keratotic surface | No umbilication. Rough, Not smooth. Black dots. |
| Milia | White, Firm keratin cysts | Smaller. No umbilication. Face. No central core. |
| Folliculitis | Hair-centred pustules | Pustular. Tender. Hair-centred. |
| Keratosis Pilaris | Rough, Follicular papules | Arms/Thighs. Plugged follicles. No umbilication. |
| Lichen Planus | Polygonal, Flat-topped, Purple | Wickham striae. Different morphology. |
| Cryptococcosis (HIV) | Umbilicated papules | Immunocompromised. Systemic symptoms. Culture. |
| Histoplasmosis (HIV) | Disseminated papules | Systemic illness. Immunocompromised. |
| Insect Bites | Pruritic papules | Central punctum. Different pattern. Clustering. |
| Basal Cell Carcinoma | Pearly papule (Adults) | Adults only. Single lesion. Rolled edge. Telangiectasia. |
Management Algorithm

Key Principles
| Principle | Details |
|---|---|
| Watchful Waiting is First-Line | Self-limiting condition. Explain natural history. |
| Treatment Does Not Always Shorten Course | Evidence is mixed. May just treat visible lesions. |
| Treatment Has Risks | Pain, Scarring, Psychological trauma in children |
| Avoid Over-Treatment | Lesions will resolve. Harm may outweigh benefit. |
| Treat Comorbidities | Eczema, Secondary infection if present |
| Special Populations | Immunocompromised need active treatment |
First-Line: Watchful Waiting (Preferred)
Strong Rationale:
- Self-limiting in immunocompetent children
- Resolves within 6-18 months (Up to 4 years in some cases)
- Treatment is often painful for children
- Treatment may cause scarring (Permanent harm for temporary condition)
- Treatment does not significantly shorten course
- No evidence of reduced transmission with treatment
- Cochrane review: No treatment clearly better than waiting
- BOTE sign (Inflammation around lesions) indicates resolution is imminent
Parental Counseling Points:
| Topic | What to Say |
|---|---|
| Nature of Condition | "This is a very common, Harmless viral skin infection. Like most childhood viruses, It will go away on its own." |
| Duration | "It usually clears within 6-18 months, Sometimes longer. The immune system eventually fights it off." |
| The 'Red, Angry' Stage | "If the spots become red and inflamed, This is actually good news – it means they're about to go away. We call this the 'beginning of the end'." |
| Treatment | "Treatment options exist but are often painful and may leave scars. Since the spots will go anyway, We usually recommend leaving them alone." |
| Contagion | "It can spread by touching. Try not to let your child scratch them. Not sharing towels helps reduce spread at home." |
| School/Swimming | "No need to keep off school. Covering spots in the pool is optional – There's no strong evidence pools spread it." |
| When to Return | "Come back if spots look infected (Red, Oozing pus), If they're near the eyes and causing problems, Or if you're worried." |
Practical Advice for Parents:
| Advice | Explanation |
|---|---|
| Don't Pick or Scratch | This spreads the spots to new areas (Autoinoculation) |
| Keep Nails Short | Reduces spread if scratching occurs |
| Separate Towels | Reduce household transmission risk |
| Don't Share Baths | Close contact in water may spread |
| Emollients/Moisturiser | Keep skin hydrated, Especially if eczema |
| No School Exclusion | Not required by guidelines |
| Covering in Pool | Optional. Reduces anxiey. Waterproof plaster/Rash guard. |
| Watch for BOTE | Inflammation means resolution is near |
| Watch for Infection | Spreading redness, Pus, Warmth → See doctor |
Indications for Active Treatment
| Indication | Reason | Treatment Choice |
|---|---|---|
| Parental/Patient Request | Cosmetic concern, Psychological distress | Discuss risks. Proceed if informed consent. |
| Prevent Autoinoculation | Spreading rapidly despite advice | Treat visible lesions. Address scratching. |
| Symptomatic Lesions | Itchy, Causing distress | May reduce itch with treatment. |
| Eyelid/Periocular Lesions | Risk of conjunctivitis, Keratitis | Careful treatment. Ophthalmology if needed. |
| Immunocompromised | Won't resolve spontaneously | Active treatment required. |
| Genital Lesions (Adults) | STI context, Reduce transmission | Treat to reduce spread. STI screen. |
| Secondary Infection | Bacterial superinfection | Treat infection + Consider lesion treatment |
| About to Heal (BOTE) | Already resolving | NO treatment needed. Reassure. |
Treatment Options - Detailed
Physical Destruction Methods:
| Method | Technique | Effectiveness | Pain | Scarring Risk | Notes |
|---|---|---|---|---|---|
| Cryotherapy (Liquid Nitrogen) | Spray or cotton bud. 5-10 seconds per lesion. -196°C. | High (70-80%) | Moderate-High | Moderate | May need repeat sessions. Hypopigmentation risk. |
| Curettage | Curette or sharp spoon scrapes off lesion | High (80-90%) | Moderate (Use EMLA) | Low-Moderate | EMLA cream 60 min before. Quick. May bleed. |
| Pricking/Expression | Pierce centre with needle, Express cheesy core | Moderate-High | Low-Moderate | Low | Technique-dependent. Risk of spread. |
| Laser (Pulsed Dye) | Vascular laser targets lesion | High | Low (With anaesthesia) | Low | Expensive. Not widely available. |
Cryotherapy – Detailed Protocol:
| Step | Details |
|---|---|
| Preparation | EMLA cream optional (Not always helpful for cryo). Position child. Distraction techniques. |
| Application | Liquid nitrogen via spray or cotton-tipped applicator. Apply until white freeze extends 1-2mm beyond lesion. |
| Duration | 5-10 seconds per lesion |
| Post-Procedure | Mild stinging/burning. Blister may form. Lesion crusts and falls off in 1-2 weeks. |
| Repeat | Review at 2-4 weeks. Repeat if needed. |
| Side Effects | Pain, Blistering, Temporary hypopigmentation, Scarring rare |
Curettage – Detailed Protocol:
| Step | Details |
|---|---|
| Preparation | Apply EMLA cream under occlusion 60 minutes before. Explain to child. |
| Technique | Use curette or sharp spoon. Scoop/scrape lesion off skin surface. Applies to base. |
| Haemostasis | Brief pressure. Cautery not usually needed. |
| Post-Procedure | Simple dressing. Clean wound. May have small wound that heals in 1-2 weeks. |
| Side Effects | Minor bleeding, Pain if EMLA inadequate, Small scar possible |
Topical Treatments - Detailed:
| Agent | Mechanism | Protocol | Effectiveness | Side Effects |
|---|---|---|---|---|
| Potassium Hydroxide (KOH) 5-10% | Caustic destruction | Apply to lesion 1-2x daily with cotton bud. Avoid normal skin. Continue until lesion inflamed. | Moderate-High (60-70%) | Irritation, Burns if spread, Stinging |
| Imiquimod 5% Cream | Immune modulator (TLR7 agonist) | Apply 3x/week at night. Wash off in morning. 4-16 weeks. | Variable (40-60%) | Erythema, Erosion, Flu-like symptoms, Off-label, Expensive |
| Podophyllotoxin 0.5% | Cytotoxic (Mitotic inhibitor) | Apply 2x/day for 3 days, Rest 4 days. Repeat weekly x4. | Moderate | Irritation. Genital MC in adults. Not children. |
| Salicylic Acid | Keratolytic | Daily application. Cover with plaster. | Low-Moderate | Irritation. Limited evidence. |
| Tretinoin 0.025-0.05% | Retinoid (Keratolytic) | Nightly application | Low | Irritation. Limited evidence. |
| Cantharidin 0.7% | Vesicant (Blister agent) | Applied in clinic. Cover. Wash off after 4-6 hours. | High (70-80%) | Blistering (Expected). Not widely available. |
| Silver Nitrate | Caustic | Apply to lesion | Moderate | Staining, Burns |
| Hydrogen Peroxide (Stabilised) | Oxidative destruction | Applied daily | Variable | Limited evidence |
Treatment Comparison:
| Treatment | Effectiveness | Pain | Scarring | Accessibility | Cochrane Evidence |
|---|---|---|---|---|---|
| Watchful Waiting | Natural resolution | None | None | N/A | Supported |
| Cryotherapy | High | High | Moderate | Good | Low quality evidence |
| Curettage | High | Moderate | Low | Good | Low quality evidence |
| KOH Topical | Moderate-High | Low-Moderate | Low | Variable | Moderate evidence |
| Imiquimod | Variable | Low | Low | Good (Prescription) | Mixed results |
| Cantharidin | High | Low (Blisters later) | Low | Poor (Availability) | Low quality |
Treatment for Molluscum Dermatitis
| Feature | Management |
|---|---|
| What it is | Eczematous reaction around molluscum lesions. Immune response. Not infection. |
| Symptoms | Itch, Erythema, Scaling around lesions |
| Treatment | Emollients (Generous application). Mild topical corticosteroid (Hydrocortisone 1%) for 5-7 days. |
| Prognosis | Resolves as molluscum resolves. May indicate BOTE. |
Management in Immunocompromised
| Principle | Details |
|---|---|
| Disease Behaviour | Extensive, Giant, Recalcitrant, May not spontaneously resolve |
| First Step | Optimise underlying condition. In HIV: Start/Optimise ART → Lesions may resolve with immune reconstitution |
| Active Treatment | Required. Aggressive approach. Physical methods + Topicals. Multiple sessions. |
| Imiquimod | May be helpful (Immune activation) |
| Cidofovir | Topical or IV. Severe, Refractory cases. Specialist use. Nephrotoxic. |
| Referral | Dermatology, Immunology, ID specialist |
Follow-Up
| Scenario | Follow-Up |
|---|---|
| Watchful Waiting | Review if concerned, Infected, Or after 12-18 months if not resolving |
| After Treatment | Review at 2-4 weeks for repeat treatment if needed |
| Immunocompromised | Regular specialist follow-up |
Referral Criteria
| Indication | Referral Target |
|---|---|
| Extensive/Giant Molluscum | Dermatology, Consider HIV testing |
| Immunocompromised | Dermatology + Immunology |
| Eyelid Lesions Causing Symptoms | Ophthalmology (If conjunctivitis/keratitis) |
| Uncertain Diagnosis | Dermatology (Biopsy if needed) |
| Treatment-Resistant | Dermatology for specialist options |
Overview
| Category | Examples | Frequency |
|---|---|---|
| Complications of Disease | Spread, Infection, Dermatitis, Ocular involvement | Common |
| Complications of Treatment | Scarring, Pain, Pigment changes | Variable by treatment |
| Psychological | Anxiety, Embarrassment, School avoidance | Occasional |
Complications of Disease - Detailed
Autoinoculation (Self-Spreading):
| Aspect | Details |
|---|---|
| Frequency | Very Common |
| Mechanism | Scratching introduces virus to new sites |
| Risk Factors | Itchy lesions, Eczema, Young children who scratch |
| Prevention | Keep nails short, Discourage scratching, Treat itch |
| Outcome | May significantly increase lesion count |
Secondary Bacterial Infection:
| Aspect | Details |
|---|---|
| Frequency | 10-20% of cases |
| Causative Organism | Usually Staphylococcus aureus |
| Clinical Features | Spreading erythema, Warmth, Tenderness, Pustules, Crusting |
| Differentiate from BOTE | BOTE = Localised inflammation. Infection = Spreading, Pus. |
| Treatment | Topical antibiotics (Fusidic acid). Oral antibiotics if extensive (Flucloxacillin). |
| Prevention | Avoid scratching, Good hygiene |
Molluscum Dermatitis:
| Aspect | Details |
|---|---|
| Frequency | 10-30% |
| What it is | Eczematous reaction around molluscum lesions |
| Mechanism | Immune response to virus, Not infection |
| Clinical Features | Erythema, Scaling, Itch around lesions |
| Treatment | Emollients (Generous). Mild topical corticosteroid (HC 1%) for 5-7 days. |
| Prognosis | Resolves as molluscum resolves. May indicate BOTE. |
| Note | May mimic bacterial infection. Check for pus to differentiate. |
Eyelid Lesions and Ocular Complications:
| Complication | Frequency | Clinical Features | Management |
|---|---|---|---|
| Chronic Follicular Conjunctivitis | Common if eyelid MC | Red eye, Gritty feeling, Discharge | Treat MC. Ophthalmology if persists. |
| Corneal Involvement | Rare | Keratitis, Pannus formation | Urgent ophthalmology referral |
| Ptosis | Rare | If large lesion on lid | May need treatment of lesion |
Psychological and Social Complications:
| Complication | Frequency | Notes |
|---|---|---|
| Parental Anxiety | Very Common | Concern about appearance, Contagion |
| Child Embarrassment | Occasional | Especially if facial or numerous |
| School Issues | Occasional | Pressure for exclusion (Not required) |
| Social Avoidance | Occasional | Avoiding swimming, Playdates |
| Self-Esteem Issues | Rare | If prolonged or extensive |
Scarring (From Disease):
| Aspect | Details |
|---|---|
| Frequency | Rare if untreated |
| When it Occurs | If secondarily infected, Severely inflamed BOTE, Picked/Traumatised |
| Type | Usually small, Atrophic scars |
| Prevention | Avoid scratching, Treat infection promptly |
Post-Inflammatory Pigment Changes:
| Type | Frequency | Duration | Outcome |
|---|---|---|---|
| Hypopigmentation | Occasional | Weeks-Months | Usually temporary. Repigments. |
| Hyperpigmentation | Occasional | Weeks-Months | Usually fades. |
Complications of Treatment - Detailed
| Treatment | Complications | Prevention/Management |
|---|---|---|
| Cryotherapy | Pain (Significant in children), Blistering (Expected), Scarring (Occasional), Hypopigmentation (Especially dark skin), Infection (Rare) | Use EMLA if tolerated. Warn about blisters. Consider risks vs. benefits. |
| Curettage | Pain (If EMLA inadequate), Bleeding (Minor), Scarring (Small risk), Infection (Rare) | EMLA cream essential. Haemostasis. Wound care. |
| KOH Topical | Irritation, Stinging, Chemical burns if on normal skin, Hypopigmentation | Careful application. Avoid surrounding skin. Stop if severe irritation. |
| Imiquimod | Erythema, Erosion, Ulceration, Flu-like symptoms (Rare), Expensive | Use as directed. May need breaks. Not licensed for MC. |
| Cantharidin | Blistering (Expected - Mechanism), Pain from blister, Scarring (Rare) | Apply carefully. Warn about blister formation. |
| Podophyllotoxin | Irritation, Ulceration, Not for children | Adult genital use only. |
Complications vs. Watchful Waiting
| Approach | Potential Complications |
|---|---|
| Watchful Waiting | Autoinoculation (Spread), Possible secondary infection if scratched, Prolonged duration |
| Active Treatment | Pain (Procedure), Scarring, Pigment changes, Incomplete treatment, Recurrence from missed lesions |
Key Point: For most children, The complications of treatment (Especially scarring) outweigh the complications of the disease itself.
Natural History - Detailed
| Phase | Duration | Description |
|---|---|---|
| Incubation | 2-6 weeks (Up to 6 months) | Virus acquired. No visible lesions yet. |
| Early Active Disease | Weeks-Months | New lesions appearing. May spread via autoinoculation. |
| Peak Disease | Variable | Maximum number of lesions. Waxing and waning. |
| BOTE Phase | 1-4 weeks per lesion | Lesions become inflamed. Immune recognition. |
| Resolution | Weeks per lesion | Individual lesions resolve. May have new ones appearing simultaneously. |
| Complete Clearance | 6-18 months (Up to 4 years) | All lesions gone. |
| Post-Resolution | Weeks-Months | Any pigment changes fade. Scarring rare. |
Outcomes by Population
| Population | Typical Outcome | Notes |
|---|---|---|
| Immunocompetent Children | Complete resolution in 6-18 months (90%+) | Excellent prognosis |
| Children with Eczema | May have more lesions, Longer duration | Usually still resolves |
| Immunocompromised | May not resolve spontaneously. Extensive. | Requires treatment and management of underlying condition. |
| Adults (Genital) | Similar resolution | STI considerations. Partner notification. |
Outcomes with Different Approaches
| Approach | Outcome | Scarring Risk | Notes |
|---|---|---|---|
| Watchful Waiting | Greater than 90% complete resolution. Average 12-18 months. | Very Low | Preferred for most children. |
| Cryotherapy | Clears treated lesions. May recur. | Moderate | May not shorten overall course. |
| Curettage | Clears treated lesions. | Low-Moderate | Quick. May miss some. |
| KOH Topical | 60-70% clearance. | Low | Home treatment option. |
| Imiquimod | Variable (40-60%) | Low | Prolonged course. Off-label. |
Recurrence
| Aspect | Details |
|---|---|
| True Recurrence Rate | Less than 5% |
| Apparent Recurrence | Often new lesions from autoinoculation or incomplete treatment |
| Post-Treatment Recurrence | More common if not all lesions treated |
| Immunity | Most develop immunity. Repeat infections uncommon. |
Prognostic Factors - Detailed
Favourable Prognosis:
| Factor | Why |
|---|---|
| Immunocompetent | Immune system will clear virus |
| Limited Number (Less than 20) | Easier for immune system. Less autoinoculation. |
| BOTE Sign Appearing | Active immune clearance |
| No Underlying Eczema | Intact skin barrier. Less scratching. |
| Single Anatomical Site | Limited spread |
| Older Child | May have partial immunity. Less scratching. |
Unfavourable Prognosis (Prolonged/Extensive):
| Factor | Why | Management |
|---|---|---|
| Immunocompromised (HIV, Primary, Iatrogenic) | Impaired T-cell immunity. Won't clear spontaneously. | Optimise immunity. Active treatment. Specialist. |
| Atopic Dermatitis | Impaired skin barrier. More lesions. More autoinoculation. | Treat eczema aggressively. Emollients. |
| Large Number (Greater than 50) | More sources for spread. Longer to clear. | May consider treatment. Investigate immunodeficiency. |
| Absence of BOTE Reaction | Suggests poor immune recognition | May need longer. |
| High Scratching | Autoinoculation. Spread. | Address scratching. Short nails. Bandages. |
| Young Child (Less than 2 years) | More scratching. Takes longer. | Watchful waiting still appropriate. |
Long-Term Outcomes
| Outcome | Frequency | Notes |
|---|---|---|
| Complete Resolution Without Scarring | Greater than 90% (Untreated) | Expected in most children |
| Minor Scarring | 5-10% | More common with treatment or infection |
| Significant Scarring | Less than 2% | Usually from repeated traumatic treatments |
| Permanent Immunity | Most | Repeat infection uncommon |
| Psychological Recovery | Excellent | Once gone, No lasting impact |
Key Guidelines
| Guideline | Organisation | Key Recommendations |
|---|---|---|
| BAD Guidelines | British Association of Dermatologists (2017) | Watchful waiting first-line. Treatment options if indicated. |
| AAD Position | American Academy of Dermatology | Self-limiting. Treatment for specific indications. |
Evidence Summary
Watchful Waiting vs Treatment (Cochrane 2017)
- Systematic review
- Result: No single treatment proven clearly superior to no treatment
- Most lesions resolve spontaneously within 12-24 months
- Quality of evidence: Low for most interventions
- PMID: 28643307
Potassium Hydroxide (Metanalysis)
- Multiple studies
- Result: Effective, Comparable to cryotherapy
- Less painful than cryotherapy when used correctly
- PMID: Various
Evidence Strength
| Intervention | Level | Notes |
|---|---|---|
| Watchful Waiting | 2a | Cochrane supports. First-line. |
| Cryotherapy | 2b | Effective but painful |
| Curettage | 2b | Effective. Skilld required. |
| KOH Topical | 2a | Multiple RCTs support. |
| Imiquimod | 2b | Off-label. Variable results. |
What is Molluscum Contagiosum?
Molluscum contagiosum is a very common and completely harmless viral skin infection that causes small, raised bumps on the skin. It is caused by a virus related to the chickenpox virus family.
Key Points:
- Extremely common in children aged 1-10 years
- Completely harmless – causes no internal illness
- Will go away on its own without treatment
- Not a sign of anything serious
What Do The Spots Look Like?
| Feature | Description |
|---|---|
| Size | Small – usually 2-5mm (about the size of a pencil eraser) |
| Shape | Round, Dome-shaped bumps |
| Colour | Flesh-coloured, Pinkish, or Pearly white |
| Surface | Smooth and shiny |
| Special Feature | Often have a tiny dimple or dent in the centre (Like a belly button) |
| Number | Can range from just a few to dozens or more |
| Location | Can appear anywhere – Face, Arms, Trunk, Legs, Armpits |
What They're NOT:
- Not usually red (Unless healing or infected)
- Not painful (Unless infected)
- Not usually itchy (Though surrounding skin may become dry)
How Did My Child Get This?
The virus spreads by:
| Method | How it Happens |
|---|---|
| Direct Touch | Skin-to-skin contact with someone who has the spots |
| Self-Spreading (Scratching) | If your child scratches one spot and then touches another area, They can spread the virus to themselves |
| Sharing Things | Sharing towels, Clothes, Bath toys with someone who has molluscum |
| Swimming/Bathing | Possibly through sharing pool surroundings (Not proven to be from the water itself) |
Who is at Risk?
- Children aged 1-10 (Most common)
- Children with eczema (Dry skin makes it easier for the virus to spread)
- Anyone who has close contact with an infected person
Does It Need Treatment?
Usually NO – And Here's Why:
| Reason | Explanation |
|---|---|
| Self-Limiting | The spots WILL go away on their own – Your child's immune system will fight off the virus |
| Duration | Usually within 6-18 months, Sometimes up to 2 years |
| Treatment Can Be Painful | Freezing, Scraping, Or chemicals can hurt – This is hard for young children |
| Treatment May Scar | The treatments can leave permanent marks. The spots usually heal without any scarring if left alone. |
| Treatment Doesn't Speed Up Resolution Significantly | Evidence shows treatments mainly remove visible spots. The virus may still cause new spots. |
When Treatment Might Be Considered:
| Situation | Why Treat |
|---|---|
| Very distressing | If the spots are really bothering your child or the family |
| Near the eyes | If spots are on the eyelids and causing eye irritation |
| Spreading rapidly | If new spots appear frequently despite care |
| Weak immune system | Children with immune problems may need treatment |
| Significant concern | After understanding the pros and cons, Some families still prefer treatment |
The 'Beginning of the End' (BOTE Sign)
This is GOOD NEWS!
[!TIP] If the spots become red, Swollen, And a bit tender – Don't panic!
This is called the "Beginning of the End" or BOTE sign. It means your child's immune system has finally recognised the virus and is fighting it. These inflamed spots will heal and disappear within 1-4 weeks.
This is NOT an infection. It's the body's natural healing response.
How to tell the difference:
| BOTE (Normal Healing) | Infection (Need to See Doctor) |
|---|---|
| Spots become red and puffy | Spreading redness beyond the spot |
| May be slightly tender | Increasing pain and tenderness |
| No pus or discharge | Yellow/Green pus or weeping |
| Child otherwise well | Child unwell, Fever |
| Spots start shrinking | Spots getting bigger |
What Can I Do At Home?
Practical Tips:
| Action | Why It Helps |
|---|---|
| Don't pick or scratch | Scratching spreads the virus to new areas |
| Keep nails short | Less damage if accidental scratching |
| Separate towels | Each family member should have their own towel |
| No shared baths | Bathe children separately if possible |
| Use moisturiser | Especially if dry skin or eczema – Healthy skin is more resistant |
| Cover if swimming | Optional – Waterproof plaster or rash guard for peace of mind |
| Reassure your child | Avoid making them feel embarrassed – It's very common |
School and Activities
| Activity | Guidance |
|---|---|
| School/Nursery | NO exclusion required. Can attend normally. |
| Swimming | Can still swim. Consider covering spots. |
| Sports | Can participate. Cover spots if contact sport. |
| Playdates | Can socialise. Avoid direct contact with spots. |
When to See a Doctor
Routine Appointment:
- If you want to discuss treatment options
- If spots are spreading very rapidly
- If you're unsure about the diagnosis
- If eczema around spots is difficult to control
See Doctor Sooner if:
- Spots look infected (Red spreading, Pus, Warmth)
- Spots near the eyes are causing irritation or discharge
- Your child has a known immune system problem
- Spots are causing significant distress
Emergency (Rare):
- Signs of severe skin infection (Large area of spreading redness, Your child is unwell with fever)
Frequently Asked Questions
Q: How long will these spots last? A: Usually 6-18 months. Sometimes up to 2 years. They will go away eventually.
Q: Will they scar? A: If left alone, They rarely leave scars. Treatment is more likely to cause scarring than the spots themselves.
Q: Are they contagious? A: Yes, The virus can spread by touch. However, Many children are exposed and never get it. It's not highly contagious like chickenpox.
Q: Can my child go to school? A: Yes! There's no need to stay off school or nursery. Guidelines say no exclusion is required.
Q: Can my child go swimming? A: Yes. You can cover the spots with a waterproof plaster or rash guard if you prefer. There's no strong evidence that pools spread the virus.
Q: Should we treat them? A: Usually no. Treatment options exist but are often painful and may scar. Since they go away on their own, We generally recommend waiting.
Q: Why are they spreading? A: Likely from scratching (The virus spreads from one spot to another). Try to discourage scratching and keep nails short.
Q: Is it related to hygiene? A: No! Molluscum is very common in healthy children. It has nothing to do with being clean or dirty.
Q: Can adults get it? A: Yes, But it's less common. In adults, Especially if on the genitals, It may be sexually transmitted.
Q: Will my child be immune after this? A: Generally yes. Most people develop immunity after an infection and don't get it again.
Psychological and Social Support
For Your Child:
- Reassure them it's very common ("Lots of children get this")
- Don't make a big deal of the spots
- Explain they will go away
- If other children ask, A simple "It's just a skin thing that will go away" is enough
For Parents:
- It can be frustrating waiting for them to go – This is normal
- Other parents may worry about contagion – You can explain it's not highly contagious
- If you feel pressured to keep your child home, Guidelines say this is not necessary
Visual Guide
What to Look For:
| Stage | Appearance |
|---|---|
| New Spot | Small, Flesh-coloured papule. May not have central dimple yet. |
| Established | Classic dome-shape with central dimple. Shiny. |
| BOTE (Healing) | Red, Swollen, Tender. About to go away. |
| Resolving | Shrinking, Crusting, Disappearing. |
| Healed | May be slight temporary discolouration. Usually no scar. |
Support Resources
| Resource | Details |
|---|---|
| NHS Website | www.nhs.uk – Search "Molluscum contagiosum" |
| BAD Patient Information | www.bad.org.uk – British Association of Dermatologists |
| Your GP/Health Visitor | First point of contact for concerns |
| Dermatology | If referral needed for complex cases |
Primary Guidelines
-
Olsen JR, et al. Molluscum contagiosum, Childhood. BMJ Clin Evid. 2015. PMID: 26068792
-
van der Wouden JC, et al. Interventions for cutaneous molluscum contagiosum. Cochrane Database Syst Rev. 2017;5:CD004767. PMID: 28643307
-
British Association of Dermatologists. Patient Information: Molluscum Contagiosum. BAD. 2017.
Evidence
-
Forbat E, et al. Molluscum contagiosum: Review and update on management. Pediatr Dermatol. 2017;34(5):504-515. PMID: 28884896
-
Hanson D, Diven DG. Molluscum contagiosum. Dermatol Online J. 2003;9(2):2. PMID: 12639455
-
Chen X, et al. Topical treatments for molluscum contagiosum. Cochrane Database Syst Rev. 2013;3:CD010118.
-
Katz KA. Dermatologists, Imiquimod, and treatment of molluscum contagiosum in children. JAMA Dermatol. 2015;151(2):125-126. PMID: 25354321
Additional References
-
Brown J, et al. Childhood molluscum contagiosum. Int J Dermatol. 2006;45(2):93-99. PMID: 16445497
-
Dohil MA, et al. The epidemiology of molluscum contagiosum in children. J Am Acad Dermatol. 2006;54(1):47-54. PMID: 16384754
-
Shisler JL. Immune evasion strategies of molluscum contagiosum virus. Adv Virus Res. 2015;92:201-252. PMID: 25701888
-
Silverberg NB. Pediatric molluscum contagiosum: Optimal treatment strategies. Paediatr Drugs. 2003;5(8):505-512. PMID: 12906691
-
Sladden MJ, Johnston GA. Common skin infections in children. BMJ. 2004;329(7457):95-99. PMID: 15242916
-
Tyring SK. Molluscum contagiosum: The importance of early diagnosis and treatment. Am J Obstet Gynecol. 2003;189(3 Suppl):S12-16. PMID: 14532897
-
Leung AKC, et al. Molluscum contagiosum: An update. Recent Pat Inflamm Allergy Drug Discov. 2017;11(1):22-31. PMID: 28477684
-
Meza-Romero R, et al. Treatment of molluscum contagiosum with potassium hydroxide. Dermatol Ther. 2019;32(2):e12806. PMID: 30652385
High-Yield Facts for Exams
| Category | Key Points |
|---|---|
| Definition | Benign, Self-limiting viral infection (MCV, Poxviridae) |
| Pathognomonic Feature | Umbilicated (Central dimple) dome-shaped papules |
| Histology | Henderson-Patterson bodies (Molluscum bodies) |
| Peak Age | 1-10 years |
| Duration | 6-18 months (Up to 4 years) |
| First-Line Management | Watchful waiting |
| BOTE Sign | Beginning Of The End - Inflammation signals resolution |
| Red Flag | Giant/Extensive molluscum = Consider immunodeficiency |
Common Exam Questions
Short Answer Questions:
-
Clinical Scenario: "A 5-year-old presents with multiple small, Dome-shaped, Umbilicated papules on the trunk. What is the diagnosis and management?"
- Answer: Molluscum contagiosum. Management: Watchful waiting (Self-limiting). Reassure parents.
-
Pathognomonic Finding: "What is the characteristic histological finding in molluscum contagiosum?"
- Answer: Henderson-Patterson bodies (Large eosinophilic intracytoplasmic inclusion bodies).
-
BOTE Sign: "What is the BOTE sign in molluscum contagiosum?"
- Answer: Beginning Of The End – Inflammation around lesions indicates immune response and impending resolution.
-
Red Flag: "When should you be concerned about molluscum contagiosum?"
- Answer: Giant molluscum (greater than 1cm), Extensive disease, Recalcitrant lesions → Suggests immunodeficiency (e.g., HIV).
-
Treatment Options: "What are the treatment options for molluscum if intervention is required?"
- Answer: Cryotherapy, Curettage, Potassium hydroxide topical, Imiquimod.
MCQ-Style Questions:
-
Best Answer: "A 4-year-old has 15 flesh-coloured papules with central dimples on his arms. Parents ask about treatment. What is the best advice?"
- A) Prescribe imiquimod
- B) Arrange curettage under general anaesthetic
- C) Reassure and advise watchful waiting ✓
- D) Urgent referral to dermatology
- E) Prescribe oral aciclovir
-
Diagnosis: "Which of the following best describes the causative organism?"
- A) Herpesvirus
- B) Papillomavirus
- C) Poxvirus ✓
- D) Retrovirus
- E) Adenovirus
-
Complication: "A child with molluscum develops red, swollen, tender lesions. What is the most likely explanation?"
- A) Secondary bacterial infection
- B) Beginning Of The End (BOTE) ✓
- C) Allergic reaction
- D) HSV superinfection
- E) Impetigo
OSCE Stations
Station 1: Clinical Examination
| Component | Required Content |
|---|---|
| Introduction | Introduce self, Confirm patient identity, Explain examination |
| Consent | Obtain consent for skin examination |
| Inspection | Describe: Dome-shaped papules, Central umbilication, Distribution, Number, Colour |
| Dermoscopy | Describe clover-leaf/Crown vessel pattern if asked |
| Surrounding Skin | Comment on molluscum dermatitis if present, Eczema |
| Red Flags | Comment on size (Giant?), Number (Extensive?), Suggest immunodeficiency if applicable |
| Summary | "This child has multiple dome-shaped, umbilicated papules consistent with molluscum contagiosum" |
Station 2: History and Counseling
| Question Area | Key Points |
|---|---|
| History Taking | Duration, Spread, Treatments tried, Eczema history, Symptoms, School concerns |
| Counseling | Explain diagnosis, Benign nature, Self-limiting (6-18 months), BOTE sign reassurance, Treatment options (Pros and cons), School guidance (No exclusion) |
Station 3: Parent Communication
| Scenario | Approach |
|---|---|
| "Parent requests treatment" | Acknowledge concern. Explain natural history. Discuss treatment risks (Pain, Scarring). Shared decision if still want treatment. |
| "Parent worried about contagion" | Explain transmission. Not highly contagious. Practical advice (Separate towels). School attendance OK. |
| "Parent worried about scarring" | Reassure: Untreated lesions rarely scar. Treatment more likely to scar. |
Viva Points
Opening Statement:
"Molluscum contagiosum is a common, Benign, Self-limiting viral skin infection caused by the Molluscum Contagiosum Virus, A poxvirus. It is characterised by dome-shaped, Umbilicated papules and is most common in children aged 1-10 years. It typically resolves spontaneously within 6-18 months, And therefore watchful waiting is the first-line management."
Key Facts to Mention:
| Fact | Details |
|---|---|
| Virus | Poxviridae family, MCV-1 most common in children |
| Transmission | Direct contact, Autoinoculation, Fomites |
| Appearance | Umbilicated papules – Central dimple is pathognomonic |
| Prognosis | Self-limiting in immunocompetent (6-18 months) |
| BOTE | Inflammation = Resolution imminent |
| First-Line | Watchful waiting |
| Histology | Henderson-Patterson bodies |
Classification to Quote:
- "MCV has subtypes: MCV-1 (Children) and MCV-2 (Adults, Sexually transmitted)"
Evidence to Cite:
- "A Cochrane review (2017) found no single treatment clearly superior to watchful waiting in immunocompetent children"
- "PMID 28643307"
Common Mistakes
What Fails Candidates:
| Mistake | Why It's Wrong |
|---|---|
| ❌ Over-treating | Recommending cryotherapy for every child. First-line is watchful waiting. |
| ❌ Not knowing BOTE | Missing this high-yield sign that signals resolution |
| ❌ Forgetting Henderson-Patterson bodies | Classic histology finding |
| ❌ Missing immunodeficiency link | Extensive disease warrants HIV testing |
| ❌ Confusing with warts | Warts have rough surface, No umbilication |
| ❌ Saying "treatment shortens disease" | Evidence doesn't strongly support this |
Dangerous Errors:
- ⚠️ Missing immunodeficiency in extensive/Giant molluscum
- ⚠️ Aggressive treatment causing scarring in a self-limiting condition
- ⚠️ Prescribing aciclovir (Wrong virus family)
Outdated Practices:
- Routine treatment of all cases – Now watchful waiting preferred
- School exclusion – Not required
Examiner Follow-Up Questions
| Question | Model Answer |
|---|---|
| "What if the lesions are on the eyelid?" | May cause conjunctival irritation. Consider ophthalmology referral if symptomatic. Treatment may be indicated. |
| "What is molluscum dermatitis?" | Eczematous reaction around lesions. Not infection. Immune response. Treat with emollients and HC 1%. |
| "Can children go to school?" | Yes. No exclusion required. Cover lesions if swimming (Optional). |
| "What if an adult presents with genital molluscum?" | Likely sexually transmitted. Consider STI screening. Partner notification. |
| "What is the evidence for treatment?" | Cochrane 2017: No single treatment clearly superior to watchful waiting. Low quality evidence for most. |
| "How would you counsel a parent who insists on treatment?" | Explain risks and benefits. If they still want treatment, Discuss options (KOH, Curettage). Shared decision. Document discussion. |
| "What is the incubation period?" | 2-6 weeks, Can be up to 6 months. |
| "What is the difference between MCV-1 and MCV-2?" | MCV-1: Children, Non-sexual. MCV-2: Adults, Often sexually transmitted. |
Differential Diagnosis Discussion
| If Asked... | Answer |
|---|---|
| "What else could this be?" | Warts (Rough surface), Milia (No umbilication), Folliculitis (Pustular), Insect bites, Keratosis pilaris |
| "How would you exclude warts?" | Warts: Rough, Keratotic, No central dimple. May have black dots (Thrombosed capillaries). |
| "What if immunocompromised?" | Consider Cryptococcosis, Histoplasmosis (Systemic symptoms in HIV). Biopsy if uncertain. |
Last Reviewed: 2025-12-25 | MedVellum Editorial Team
Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists and current guidelines.